Calcium Channel Inhibitors

N-type calcium channel

L-type calcium channel

P/Q-type calcium channel

T-type calcium channel

Calcium Channel

Calcium Channel Inhibitors, Agonists, Antagonists, Activators & Modulators

Product Name	N-type calcium channel	L-type calcium channel	P/Q-type calcium channel	T-type calcium channel	Calcium Channel	Purity
L-Ascorbic acid				T-type calcium channel		99.97%
Minocycline hydrochloride		L-type calcium channel				99.79%
L-Ascorbic acid sodium salt				T-type calcium channel		99.97%
Bay K 8644		L-type calcium channel, EC₅₀: 17.3 nM				99.96%
Ruthenium red		L-type calcium channel
Amlodipine		L-type calcium channel				99.76%
Ethacrynic acid		L-type calcium channel				99.98%
Flufenamic acid		L-type calcium channel				99.93%
Diltiazem hydrochloride		L-type calcium channel				99.04%
Mibefradil dihydrochloride		L-type calcium channel		T-type calcium channel		≥98.0%
Diacerein		L-type calcium channel				98.78%
Isradipine		L-type calcium channel				99.89%
Felodipine		L-type calcium channel				99.35%
(S)-(-)-Bay-K-8644		L-type calcium channel				98.81%
NNC 55-0396				T-type calcium channel		≥99.0%
Flunarizine dihydrochloride				T-type calcium channel		99.87%
Ginsenoside Rd		L-type calcium channel				99.88%
Manidipine dihydrochloride				T-type calcium channel		99.91%
Urolithin C		L-type calcium channel				≥98.0%
Catharanthine		L-type calcium channel				99.65%
Amlodipine besylate		L-type calcium channel				99.91%
Ethosuximide				T-type calcium channel		99.26%
Ulixacaltamide				T-type calcium channel		98.73%
Diltiazem		L-type calcium channel				99.70%
Pinaverium bromide		L-type calcium channel				99.83%
Lomerizine dihydrochloride		L-type calcium channel				99.84%
TTA-A2				T-type calcium channel		≥99.0%
Azelnidipine		L-type calcium channel				99.66%
Ginsenoside Rf	N-type calcium channel					99.48%
Ziconotide acetate	N-type calcium channel					99.58%
Fluspirilene		L-type calcium channel				99.66%
Suvecaltamide				T-type calcium channel		99.96%
Norfluoxetine hydrochloride				Ca_V3.3, IC₅₀: 5 μM		99.58%
Amlodipine maleate		L-type calcium channel				99.87%
Drotaverine hydrochloride		L-type calcium channel				99.65%
Apinocaltamide		Ca_v1.2, IC₅₀: 2410 nM		Ca_V3.1, IC₅₀: 6.4 nM Ca_v3.2, IC₅₀: 18 nM Ca_V3.3, IC₅₀: 7.5 nM		99.83%
Etripamil		L-type calcium channel				98.80%
CaV1.3 antagonist-1		Ca_V1.3, IC₅₀: 1.7 μM				98.12%
1-Octanol				T-type calcium channel		99.63%
Barnidipine hydrochloride		L-type calcium channel				99.96%
SR33805		L-type calcium channel, EC₅₀: 4.1 nM (in depolarized conditions) L-type calcium channel, EC₅₀: 33 nM (in polarized conditions)				99.19%
Norverapamil hydrochloride		L-type calcium channel				99.80%
GV-58	N-type calcium channel, EC₅₀: 7.21 μM		P/Q-type calcium channel, EC₅₀: 8.81 μM			99.22%
Ca2+ channel agonist 1	N-type calcium channel, EC₅₀: 14.23 μM					99.71%
Psoralenoside		L-type calcium channel				99.84%
NP118809	N-type calcium channel, IC₅₀: 0.11 μM	L-type calcium channel, IC₅₀: 12.2 μM				98.73%
Ethacrynic acid (Standard)		L-type calcium channel
Cycleanine		L-type calcium channel (^[1])				99.80%
Catharanthine Tartrate		L-type calcium channel				98.88%
(2R/S)-6-PNG				T-type calcium channel		99.88%
TTA-Q6(isomer)				T-type calcium channel		99.84%
Barnidipine-d₅ hydrochloride		L-type calcium channel				≥98.0%
N-Desalkylflurazepam		Ca_v1.2, IC₅₀: 55 μM Ca_V1.3, IC₅₀: 37 μM				99.95%
CXL-1020		L-type calcium channel				≥99.0%
ω-Agatoxin TK			P/Q-type calcium channel			≥99.0%
MMK1					Calcium Channel	99.22%
Minocycline		L-type calcium channel
Ziconotide	N-type calcium channel N-type calcium channel
Ziconotide TFA	N-type calcium channel
Amlodipine mesylate		L-type calcium channel
Elgodipine		L-type calcium channel, IC₅₀: 2.3 nM		T-type calcium channel, IC₅₀: 32 nM
AT1R antagonist 3		Ca_v1.2, Ki: 0.57 μM
ω-Conotoxin Bu8	Ca_V2.2, IC₅₀: 89 nM
Barnidipine		L-type calcium channel
Calcicludine		L-type calcium channel, IC₅₀: 88 nM
Cav 3.2 inhibitor 3				Ca_v3.2, IC₅₀: 0.1534 μM
Norverapamil		L-type calcium channel
ILS-920		L-type calcium channel
ω-Conotoxin CnVIIA	N-type calcium channel
Catharanthine Sulfate		L-type calcium channel
T-Type calcium channel inhibitor 2				Ca_V3.1, IC₅₀: 31.0 μM Ca_v3.2, IC₅₀: 83.1 μM Ca_V3.3, IC₅₀: 69.3 μM
GTx1-15					Calcium Channel
N-Salicyloyltryptamine		L-type calcium channel
Cav 2.2/3.2 blocker 1	Ca_V2.2, IC₅₀: 78 μM			Ca_v3.2, IC₅₀: 80 μM
Huwentoxin XVI	N-type calcium channel
Diltiazem hydrochloride (Standard)		L-type calcium channel
LY393615			P/Q-type calcium channel, IC₅₀: 4 μM
MMK1 TFA					Calcium Channel
sFTX-3.3	N-type calcium channel, IC₅₀: 0.70 mM		P/Q-type calcium channel, IC₅₀: 0.24 mM
IDO1-IN-19					ICa, IC₅₀: 8.3 μM	98.52%
MONIRO-1	hCa_v2.2, IC₅₀: 34 μM			hCa_v3.1, IC₅₀: 3.3 μM hCa_v3.2, IC₅₀: 1.7 μM hCa_v3.3, IC₅₀: 7.2 μM		99.18%
Cavα2δ1&NET-IN-3					Calcium Channel
Diltiazem malate		L-type calcium channel
IAB15				T-type calcium channel
KTt-45				T-type calcium channel
Lomerizine		L-type calcium channel
Calciseptin		L-type calcium channel, IC₅₀: 15 nM
IAA65				T-type calcium channel
GW7845		L-type calcium channel
Triphenylethylene		L-type calcium channel
Amlodipine-d₄ maleate		L-type calcium channel
8-Br-7-CH-cADPR					Calcium Channel
PD0176078	N-type calcium channel					99.80%

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。	站点地图隐私声明
沪ICP备15051369号-4 上海工商沪公网安备31011502019417 沪(浦)应急管危经许[2021]201709(QFYS) 营业执照（三证合一）
Copyright © 2013-2024 MedChemExpress. All Rights Reserved.

MedChemExpress (MCE) 只为有资质的科研机构、医药企业基于科学研究或药证申报的用途提供医药研发服务，不为任何个人或者非科研性质的、非用于药证申报使用等其他用途提供服务。

站点地图隐私声明

沪ICP备15051369号-4